ductal carcinoma in situ PreludeDx DCIS Breast Cancer Test Helps Determine Radiation Therapy Benefits, Reduce Overtreatment Premium The test uses prognostic markers to group women based on their risk of 10-year recurrence of ductal carcinoma in situ. PreCancer Atlas Attempts to Push Precision Medicine to Early-Stage Disease Premium Cancer Moonshot-funded teams are profiling pre-cancers in an effort to establish targeted treatment, detection, and prevention methods that can be applied before cancers form. PreludeDx Receives New York State Approval for DCIS Test The company will now be able to market the test, which algorithmically weighs molecular markers and clinical information, in all 50 US states. Topographic Single-Cell Sequencing Method Yields New Insights in Breast Cancer Evolution Premium Researchers traced clonal populations with shared copy number profiles back to their location in tissue samples, confirming patterns that may have clinical relevance. Genomic Health Publishes Second Study on Prostate Test, Expects Medicare Reimbursement by Q4 Premium With more evidence for clinical utility in the scientific literature, the company expects finalized Medicare coverage before the end of the year. Aug 4, 2015 Genomic Health Posts Flat Q2 Revenues, Misses Wall Street Estimates Dec 12, 2014 Researchers Present Data from Second Validation Study of Genomic Health Oncotype DX DCIS Test Nov 5, 2014 Genomic Health Reports 5 Percent Revenue Growth in Third Quarter Aug 13, 2014 Genomic Health Focused on Validating, Driving Adoption of Prostate Cancer, DCIS Tests Premium Aug 7, 2014 Genomic Health Reports 11 Percent Revenue Jump in Second Quarter Sep 23, 2013 Analyst Downgrades Genomic Health to Underperform May 13, 2013 Medicare to Cover Genomic Health's Oncotype DX Breast Cancer Test for DCIS May 8, 2013 With 8 Percent Revenue Bump in Q1, Genomic Health Focus on Expanding Oncotype DX Franchise Premium Mar 13, 2013 Data Supports Oncotype DX for Predicting Recurrence in Node-Positive Cancers, Guiding Radiation Therapy Premium Feb 13, 2013 After 14 Percent Revenue Bump in 2012, Genomic Health Focusing on Market Growth, Prostate Dx Launch Premium Nov 14, 2012 Genomic Health Attributes Q3 Revenue Growth to Strong International Test Adoption Premium May 9, 2012 Genomic Health Partners with OncoMed to Grow Companion Dx, NGS Reach Premium Jan 9, 2012 Genomic Health Expanding Sales Force by 20 Percent; Starts Prostate Dx Studies Nov 2, 2011 Myriad Reports 20 Percent Q1 Revenue Growth, Rising Demand for Colorectal Cancer Test Premium Aug 10, 2011 Genomic Health Focuses on Oncotype DX Tests for DCIS and Colon Cancer for Future Growth Premium Feb 16, 2011 After Profitable Year, Genomic Health to Invest in New Products, Overseas Market, Next-Gen Sequencing Premium Sep 29, 2010 Genomic Health Updates Investors on Timeline for DCIS, Colon Cancer, Prostate Cancer Tests Premium Breaking News Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel Type 1 Diabetes GWAS, Fine-Mapping Leads to New Genetic Loci, Potential Drug Targets LSU Health Sciences Center Wins $2.4M to Lead SARS-CoV-2 Variant Sequencing Program The Scan Missed Early Cases A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports. Limited Journal Editor Diversity A survey finds low diversity among scientific and medical journal editors, according to The Scientist. How Much of a Threat? Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned. PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.